Breaking News Instant updates and real-time market news.

WYNN

Wynn Resorts

$122.42

-0.2 (-0.16%)

, MGM

MGM Resorts

$31.42

0.46 (1.49%)

13:10
05/19/17
05/19
13:10
05/19/17
13:10

Macau gaming regulator comments 'nothing new,' says JPMorgan

After local Chinese media quoted Paulo Chan, the director of Macau's gaming regulator, as having said that existing casino operators will have to "re-bid" for their concessions, JP Morgan analyst DS Kim said earlier that "this is nothing new" as he believes Chan was just clarifying legal terminology and statutory facts. Chan emphasized there isn't any new development regarding gaming concessions, which Kim thinks is the message he wanted to convey. Kim also said in a note issued prior to the open that his view remains that all six existing licenses will be renewed and no new license will be issued.

WYNN

Wynn Resorts

$122.42

-0.2 (-0.16%)

MGM

MGM Resorts

$31.42

0.46 (1.49%)

LVS

Las Vegas Sands

$57.10

0.25 (0.44%)

MLCO

Melco Resorts & Entertainment

$20.99

-0.27 (-1.27%)

  • 31

    May

WYNN Wynn Resorts
$122.42

-0.2 (-0.16%)

05/12/17
05/12/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Tiffany (TIF) upgraded to Buy from Neutral at Goldman Sachs analyst Lindsay Drucker Mann saying the luxury category is improving amid higher international tourist spending and a "firming" high-end U.S. consumer. 2. Bed Bath & Beyond (BBBY) upgraded to Hold from Sell at Loop Capital with analyst Anthony Chukumba citing valuation, not a more bullish view of the company's fundamentals, for the upgrade. 3. Chemours (CC) upgraded to Overweight from Neutral at JPMorgan with analyst Jeffrey Zekauskas saying the stock's multiple can expand given the company's longer-term growth opportunities. Chemours has a proprietary set of "very profitable newer generation refrigerants with patent lives extending to 2022 with excellent growth potential," Zekauskas tells investors in a research note. He raised his price target for the shares to $50 from $39. 4. TripAdvisor (TRIP) upgraded to Long-Term Buy from Neutral at Hilliard Lyons with analyst Stephen Turner citing improving underlying performance following the first quarter report. 5. Wynn Resorts (WYNN) and Las Vegas Sands (LVS) were upgraded to Overweight from Equal Weight at Barclays. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/12/17
05/12/17
UPGRADE

Overweight
Las Vegas Sands, Wynn Resorts upgraded on Macau recovery at Barclays
As previously reported, Barclays analyst Felicia Hendrix upgraded both Las Vegas Sands (LVS) and Wynn Resorts (WYNN), each to Overweight from Equal Weight, citing the recovery in Macau, which she now believes is sustainable. The Macau gaming market has been picking up steam, having posted four consecutive quarters of mass market GGR growth, and Hendrix sees this as the early stages of a multi-year growth cycle, she tells investors. The analyst, who raised her price target on Las Vegas Sands to $68 from $55 and on Wynn to $144 from $87, also keeps an unchanged Overweight rating and $34 target on casino peer MGM Resorts (MGM).
05/12/17
LEHM
05/12/17
UPGRADE
LEHM
Overweight
Wynn Resorts upgraded to Overweight from Equal Weight at Barclays
04/26/17
04/26/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Big Lots (BIG) upgraded to Strong Buy from Market Perform at Raymond James with analyst Dan Wewer saying all productivity metrics continue to improve as the company has pruned back underperforming stores and has focused on sales, productivity, EBIT%, ROIC, FCF, dividend growth, and buybacks. Wewer notes Big Lots' short interest has reached 33% and could be a benefit as the company delivers on on earnings and guidance. 2. Dynegy (DYN) upgraded to Hold from Sell at Deutsche Bank with analyst Abe Aza citing a balanced risk/reward with the stock down 30% since February's "disappointing" New England capacity auction results. The analyst raised his price target for the shares to $7 from $6. 3. L Brands (LB) upgraded to Buy on core comp, margin opportunity at Buckingham with the firm saying the worst of trends at Victoria's Secret are past and believes core comps and margin can improve going forward. 4. Wynn Resorts (WYNN) upgraded to Buy from Hold at Union Gaming. 5. BHP Billiton (BHP) upgraded to Buy from Neutral at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
MGM MGM Resorts
$31.42

0.46 (1.49%)

04/25/17
MSCO
04/25/17
NO CHANGE
MSCO
Macau forecasts raised at Morgan Stanley
Morgan Stanley analyst Thomas Allen raised Macau estimates to reflect stronger Q1 momentum, driven by the VIP segment, and increased confidence in infrastructure, such as the Taipa ferry terminal opening. As a result, the analyst raised Wynn Resorts price target to $130 from $124 and continues to believe it has the most upside versus consensus, raised Las Vegas Sands (LVS) price target to $58 from $57, and increased MGM Resorts' price target to $31 from $30.
03/08/17
STFL
03/08/17
NO CHANGE
STFL
MGM Resorts decline caused by several factors, says Stifel
Stifel analyst Steven Wieczynski blames yesterday's decline in MGM's stock on the company's statement that President Trump's travel ban "created some noise in Strip lodging trends during January and February.," a decline in National Harbor's win rate in February versus January, and the North Korea missile launch. However, the analyst notes that March has been more encouraging in Vegas so far, and he keeps a Buy rating on the shares.
03/28/17
WOLF
03/28/17
INITIATION
Target $32
WOLF
Outperform
MGM Resorts initiated with an Outperform at Wolfe Research
Wolfe Research initiated MGM Resorts with an Outperform and a $32 price target.
LVS Las Vegas Sands
$57.10

0.25 (0.44%)

05/12/17
LEHM
05/12/17
UPGRADE
LEHM
Overweight
Las Vegas Sands upgraded to Overweight from Equal Weight at Barclays
04/28/17
SUSQ
04/28/17
NO CHANGE
Target $69
SUSQ
Positive
Las Vegas Sands price target raised to $69 from $63 at Susquehanna
Susquehanna analyst Rachel Rothman raised her price target on Las Vegas Sands to $69 from $63 following solid Q1 results. The analyst cited the company's organic growth in Macau, free cash flow deployment, global portfolio and a bullish long-term outlook. Rothman reiterated her Positive rating on Las Vegas Sands shares.
MLCO Melco Resorts & Entertainment
$20.99

-0.27 (-1.27%)

04/24/17
UGAM
04/24/17
UPGRADE
UGAM
Buy
Melco Resorts & Entertainment upgraded to Buy from Hold at Union Gaming

TODAY'S FREE FLY STORIES

ROKU

Roku

$21.87

-0.16 (-0.73%)

07:25
10/23/17
10/23
07:25
10/23/17
07:25
Initiation
Roku initiated  »

Roku initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

TSRO

Tesaro

$116.40

0.89 (0.77%)

, CLVS

Clovis

$77.50

0.73 (0.95%)

07:24
10/23/17
10/23
07:24
10/23/17
07:24
Initiation
Tesaro, Clovis initiated  »

Tesaro initiated with an…

TSRO

Tesaro

$116.40

0.89 (0.77%)

CLVS

Clovis

$77.50

0.73 (0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 06

    Nov

  • 08

    Nov

NCNA

NuCana

$14.08

-0.3 (-2.09%)

07:23
10/23/17
10/23
07:23
10/23/17
07:23
Initiation
NuCana initiated  »

NuCana initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:23
10/23/17
10/23
07:23
10/23/17
07:23
General news
Futures higher ahead of buy week of earnings »

Stock futures are…

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

, DBVT

DBV Technologies

$48.07

0.92 (1.95%)

07:23
10/23/17
10/23
07:23
10/23/17
07:23
Recommendations
Aimmune, DBV Technologies analyst commentary  »

Aimmune price target…

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

FL

Foot Locker

07:23
10/23/17
10/23
07:23
10/23/17
07:23
Downgrade
Foot Locker rating change  »

Foot Locker downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXN

Texas Instruments

$95.18

1.73 (1.85%)

07:23
10/23/17
10/23
07:23
10/23/17
07:23
Recommendations
Texas Instruments analyst commentary  »

Texas Instruments price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

JPM

JPMorgan

$99.51

1.4 (1.43%)

07:22
10/23/17
10/23
07:22
10/23/17
07:22
Periodicals
JPMorgan, Mosaic Smart Data partner to boost fixed-income trading, Reuters says »

JPMorgan has teamed up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 02

    Nov

  • 05

    Nov

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

CLVS

Clovis

$77.50

0.73 (0.95%)

07:21
10/23/17
10/23
07:21
10/23/17
07:21
Initiation
Clovis initiated  »

Clovis initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BIIB

Biogen

$338.10

-4.32 (-1.26%)

, ESALY

Eisai

$53.38

-0.25 (-0.47%)

07:19
10/23/17
10/23
07:19
10/23/17
07:19
Hot Stocks
Biogen, Eisai expand existing collaboration agreement »

Eisai Co., Ltd. (ESALY)…

BIIB

Biogen

$338.10

-4.32 (-1.26%)

ESALY

Eisai

$53.38

-0.25 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

NITE

Nightstar Therapeutics

$19.00

-0.1 (-0.52%)

07:19
10/23/17
10/23
07:19
10/23/17
07:19
Initiation
Nightstar Therapeutics initiated  »

Nightstar Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCH

Potlatch

$53.00

-0.35 (-0.66%)

07:18
10/23/17
10/23
07:18
10/23/17
07:18
Earnings
Potlatch reports Q3 EPS ex-items 94c, consensus 90c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

PCH

Potlatch

$53.00

-0.35 (-0.66%)

07:18
10/23/17
10/23
07:18
10/23/17
07:18
Hot Stocks
Potlatch raises dividend to 40c per share from 37.5c per share »

Potlatch announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

SAIC

SAIC

$70.88

1.04 (1.49%)

07:18
10/23/17
10/23
07:18
10/23/17
07:18
Upgrade
SAIC rating change  »

SAIC upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

GGB

Gerdau

07:17
10/23/17
10/23
07:17
10/23/17
07:17
Initiation
Gerdau initiated  »

Gerdau resumed with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALE

Vale

07:17
10/23/17
10/23
07:17
10/23/17
07:17
Initiation
Vale initiated  »

Vale resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCCO

Southern Copper

$43.13

-0.16 (-0.37%)

07:17
10/23/17
10/23
07:17
10/23/17
07:17
Initiation
Southern Copper initiated  »

Southern Copper resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBR

Fibria Celulose

$16.24

0.45 (2.85%)

07:17
10/23/17
10/23
07:17
10/23/17
07:17
Initiation
Fibria Celulose initiated  »

Fibria Celulose resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCH

Potlatch

$53.00

-0.35 (-0.66%)

, DEL

Deltic Timber

$89.12

0.98 (1.11%)

07:17
10/23/17
10/23
07:17
10/23/17
07:17
Hot Stocks
Mike Covey to continue to serve as chairman and CEO of combined Potlatch, Deltic »

The leadership team will…

PCH

Potlatch

$53.00

-0.35 (-0.66%)

DEL

Deltic Timber

$89.12

0.98 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 02

    Nov

GOOG

Alphabet

$988.20

3.75 (0.38%)

, GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

07:17
10/23/17
10/23
07:17
10/23/17
07:17
Periodicals
Google plans to share revenues with news publishers, FT reports »

Google is planning to…

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 26

    Oct

  • 08

    Nov

  • 15

    Nov

  • 29

    Nov

  • 18

    Mar

BIIB

Biogen

$338.10

-4.32 (-1.26%)

07:16
10/23/17
10/23
07:16
10/23/17
07:16
Downgrade
Biogen rating change  »

Biogen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

PCH

Potlatch

$53.00

-0.35 (-0.66%)

, DEL

Deltic Timber

$89.12

0.98 (1.11%)

07:15
10/23/17
10/23
07:15
10/23/17
07:15
Hot Stocks
Potlatch, Deltic Timber to combine in all-stock transaction »

Potlatch Corporation…

PCH

Potlatch

$53.00

-0.35 (-0.66%)

DEL

Deltic Timber

$89.12

0.98 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 02

    Nov

PSTI

Pluristem

$1.77

-0.035 (-1.94%)

07:15
10/23/17
10/23
07:15
10/23/17
07:15
Hot Stocks
Pluristem receives European patent covering PLX-R18 »

Pluristem Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:15
10/23/17
10/23
07:15
10/23/17
07:15
General news
FX Update: The dollar traded firmer »

FX Update: The dollar…

HAL

Halliburton

$43.33

-0.09 (-0.21%)

07:14
10/23/17
10/23
07:14
10/23/17
07:14
Hot Stocks
Halliburton CEO says 'North American business is hitting on all cylinders' »

"We had a strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.